StockData
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. (SRPT) stock

SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 12/3086% below fair value
$14.53−0.24 (-1.62%)

Close on Nov 18, 2026Market cap $1.53BP/E –Yield –

Sarepta Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Sarepta Therapeutics's pe ratio was 43.7× on Jul 31, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202643.7×+17.0
2025Apr 30, 202526.7×−73.0
2024Dec 31, 202499.7×–

More Sarepta Therapeutics figures

See a number that looks wrong?